Overexpression of MDM2 could modulate various proangiogenic pathways and induce tumor angiogenesis in several tumors, including gastric cancer, breast carcinoma, prostate cancer and ovarian carcinoma [8,9]. Here, MDM2 is linked to neoplasm.